A systematic review and meta-analysis of moxibustion for chronic prostatitis.

Journal

Medicine

ISSN: 1536-5964

Titre abrégé: Medicine (Baltimore)

Pays: United States

ID NLM: 2985248R

Informations de publication

Date de publication:
15 Dec 2023

Historique:

medline: 20 12 2023

pubmed: 20 12 2023

entrez: 20 12 2023

Statut: ppublish

Résumé

Chronic prostatitis (CP) is a common condition that affects many individuals. Previous clinical trials have explored the use of moxibustion as a potential treatment for CP. However, the evidence on the effectiveness of moxibustion for CP remains limited. Therefore, this study aimed to comprehensively assess the effects of moxibustion for CP. In order to gather relevant and up-to-date information, we conducted a systematic literature search of databases including Cochrane Library, PUBMED, EMBASE, CNKI, and Wangfang from inception until June 30, 2023. Only randomized clinical trials (RCTs) that investigated the use of moxibustion for CP were included in this study. The primary outcomes of interest were the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) scores and the overall response rate. To evaluate the quality of the included studies, we used the Cochrane risk-of-bias tool. After analyzing the data from 8 RCTs involving a total of 664 patients, we found significant differences in NIH-CPSI scores between moxibustion and other treatment modalities. Specifically, when compared with herbal medicine, moxibustion was associated with a mean difference (MD) of -1.78 in NIH-CPSI scores (95% confidence interval [CI] [-2.78, -0.78], P < .001), and when compared with western medicine, moxibustion was associated with a MD of -5.24 in NIH-CPSI scores (95% CI [-7.80, -2.67], P < .08). In terms of the overall response rate, moxibustion was found to be superior to herbal medicine, with a MD of 2.36 (95% [19, 4.67], P = .01). Additionally, when moxibustion was combined with herbal medicine, it yielded a higher overall response rate with a MD of 4.07 (95% CI [1.54, 10.74], P = .005) compared to herbal medicine alone. Moxibustion also outperformed western medicine in terms of the overall response rate, with a MD of 4.56 (95% CI [2.24, 9.26], P < .001). Based on the findings of this study, moxibustion appears to be a potentially efficacious treatment for CP. The results suggest that moxibustion can improve NIH-CPSI scores and overall response rate in patients with CP. However, further high-quality studies are needed to validate these results and establish the long-term effects of moxibustion as a treatment for CP.

Sections du résumé

BACKGROUND BACKGROUND

METHODS METHODS

In order to gather relevant and up-to-date information, we conducted a systematic literature search of databases including Cochrane Library, PUBMED, EMBASE, CNKI, and Wangfang from inception until June 30, 2023. Only randomized clinical trials (RCTs) that investigated the use of moxibustion for CP were included in this study. The primary outcomes of interest were the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) scores and the overall response rate. To evaluate the quality of the included studies, we used the Cochrane risk-of-bias tool.

RESULTS RESULTS

After analyzing the data from 8 RCTs involving a total of 664 patients, we found significant differences in NIH-CPSI scores between moxibustion and other treatment modalities. Specifically, when compared with herbal medicine, moxibustion was associated with a mean difference (MD) of -1.78 in NIH-CPSI scores (95% confidence interval [CI] [-2.78, -0.78], P < .001), and when compared with western medicine, moxibustion was associated with a MD of -5.24 in NIH-CPSI scores (95% CI [-7.80, -2.67], P < .08). In terms of the overall response rate, moxibustion was found to be superior to herbal medicine, with a MD of 2.36 (95% [19, 4.67], P = .01). Additionally, when moxibustion was combined with herbal medicine, it yielded a higher overall response rate with a MD of 4.07 (95% CI [1.54, 10.74], P = .005) compared to herbal medicine alone. Moxibustion also outperformed western medicine in terms of the overall response rate, with a MD of 4.56 (95% CI [2.24, 9.26], P < .001).

CONCLUSION CONCLUSIONS

Based on the findings of this study, moxibustion appears to be a potentially efficacious treatment for CP. The results suggest that moxibustion can improve NIH-CPSI scores and overall response rate in patients with CP. However, further high-quality studies are needed to validate these results and establish the long-term effects of moxibustion as a treatment for CP.

Identifiants

DOI: 10.1097/MD.0000000000036742 PMID: 38115243

pubmed: 38115243

doi: 10.1097/MD.0000000000036742

pii: 00005792-202312150-00004

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

e36742

Informations de copyright

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Batstone GR, Doble A. Chronic prostatitis. Curr Opin Urol. 2003;13:23–9.

Zaidi N, Thomas D, Chughtai B. Management of chronic prostatitis (CP). Curr Urol Rep. 2018;19:88.

Pirola GM, Verdacchi T, Rosadi S, et al. Chronic prostatitis: current treatment options. Res Rep Urol. 2019;11:165–74.

Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, et al. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol. 2007;178:1333–7.

Roberts RO, Lieber MM, Rhodes T, et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted county study of urinary symptoms and health status among men. Urology. 1998;51:578–84.

Rizzo M, Marchetti F, Travaglini F, et al. Prevalence, diagnosis and treatment of prostatitis in Italy: a prospective urology outpatient practice study. BJU Int. 2003;92:955–9.

Nickel JC. The three as of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? BJU Int. 2004;94:1230–3.

Zhang QH, Yue JH, Sun ZR, et al. Acupuncture for chronic knee pain: a protocol for an updated systematic review. BMJ Open. 2016;6:e008027.

Zhang Q, Yue J, Zeng X, et al. Acupuncture for chronic neck pain: a protocol for an updated systematic review. Systematic Rev. 2016;5:76.

Zhang QH, Yue JH, Li CR, et al. Moxibustion for the treatment of pressure ulcers: study protocol for a pilot, multicenter, randomized controlled trial. BMJ Open. 2014;4:e006423.

Peng T, Cheng Y, Jin Y, et al. Acupuncture for chronic prostatitis: a systematic review and meta-analysis protocol. Medicine (Baltim). 2018;97:e0615.

Sun ZR, Yu NN, Yue JH, et al. Acupuncture for urinary incontinence after stroke: a protocol for systematic review. BMJ Open. 2016;6:e008062.

Yue JH, Golianu B, Zeng XX, et al. Acupuncture for urinary retention after stroke: a protocol for systematic review. Eur J Bio Med Res. 2015;1:7–11.

Wu X, Cheng K, Xu C, et al. Mechanism of acupuncture and moxibustion on chronic prostatitis/chronic pelvic pain syndrome: a narrative review of animal studies. Pain Res Manag. 2021;2021:2678242.

Yu Y, Kang J. Clinical studies on treatment of chronic prostatitis with acupuncture and mild moxibustion. J Tradit Chin Med. 2005;25:177–81.

Lai XJ. Experience in the treatment of intractable diseases with a combination of superior techniques of acupuncture and moxibustion. Chinese Acupun. 2019;39:73–6.

Wang S, Li ZJ, Yun S. Research progress in the external treatment of chronic prostatitis with traditional Chinese medicine. J Nanjing Univ Trad Chinese Med. 2014;30:297–300.

Chen Y, Zhang Q. Clinical observation on heat sensitization moxibustion therapy on acupoints for chronic bacterial prostatitis. Mod Diagn Treat. 2008;5:280–1.

Kang MF, Zhang HF, Fu Y, et al. Evaluation of clinical therapeutic effect of heat-sensitive moxibustion on chronic prostatitis with different dosage of moxibustion. Lishizhen Med Materia Medica Res. 2015;26:125–7.

Ma WJ, Hu QL. Clinical study on the treatment of chronic non-bacterial prostatitis with medicated oil moxibustion. J Trad Chin Med. 2012;24:1176–7.

Mi LH. Clinical observation of the treatment of Type IIIA prostatitis with Honglu Fang combined with Guanyuan and Gejiang moxibustion. Shanghai Univ Trad Chin Med. 2019.

Qiu JC. Clinical study on the treatment of chronic prostatitis with Ge Yao Moxibustion through the navel. Shandong Univ Trad Chin Med. 2003.

Wang WC, Ma WJ, Hu R, et al. Observation on the therapeutic effect of heat-sensitive moxibustion on Type IIIB prostatitis in 30 cases. New Trad Chin Med. 2007;39:50–1.

Wang WC, Ma WJ, Yan ZR, et al. Clinical observation of 60 cases of chronic non-bacterial prostatitis treated with medicated oil restraining and detoxification moxibustion. Chin J Trad Med. 2008;9:812–4.

Xie L, Zou QY. Clinical observation of the treatment of chronic non-bacterial prostatitis with Guize acupoint moxibustion. Chin Folk Therapy. 2022;30:47–9.

Cao Q, Zhou X, Chen J, et al. Efficacy and safety of moxibustion in patients with chronic prostatitis/chronic pelvic pain syndrome: a systematic review protocol. Medicine (Baltim). 2019;98:e15678.

Propert KJ, Litwin MS, Wang Y, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006;15:299–305.

Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.